Defining new surrogate markers for CKD progression

H. William Schnaper, Susan L. Furth, Lynne P. Yao

Research output: Contribution to journalArticle

Abstract

At a recent meeting of international experts on clinical aspects of progressive chronic kidney disease (CKD), an extensive analysis of extant clinical trials was used to develop more effective and economical surrogate markers for CKD outcomes in adults. This article describes the reasons for this undertaking, the methods and conclusions of the meeting, and the relevance of these findings to pediatric nephrology.

Original languageEnglish (US)
Pages (from-to)193-198
Number of pages6
JournalPediatric Nephrology
Volume30
Issue number2
DOIs
StatePublished - Nov 5 2015

Keywords

  • Chronic kidney disease
  • GFR
  • Kidney function
  • Locusta migratoria
  • Pediatric CKD
  • Surrogate markers

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Nephrology

Fingerprint Dive into the research topics of 'Defining new surrogate markers for CKD progression'. Together they form a unique fingerprint.

  • Cite this

    William Schnaper, H., Furth, S. L., & Yao, L. P. (2015). Defining new surrogate markers for CKD progression. Pediatric Nephrology, 30(2), 193-198. https://doi.org/10.1007/s00467-014-2995-0